Oramed Pharmaceuticals

ORMP

Oramed Pharmaceuticals, or Oramed (Hebrew: אורמד‎), is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem, Israel. Its shares are listed on the NASDAQ Capital Market.

Oramed Pharmaceuticals has been a target of short sellers for a while. The current short interest of 2.77% is roughly at the average of the last 12 months (1.37%).